The underlying mechanisms of cisplatin-induced nephrotoxicity and its therapeutic intervention using natural compounds

Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):2925-2941. doi: 10.1007/s00210-023-02559-6. Epub 2023 Jun 8.

Abstract

Cisplatin is an effective chemotherapeutic drug widely used for the treatment of various solid tumors; however, its clinical use and efficacy are limited by its inherent nephrotoxicity. The pathogenesis of cisplatin-induced nephrotoxicity is complex and has not been fully elucidated. Cellular uptake and transport, DNA damage, apoptosis, oxidative stress, inflammatory response, and autophagy are involved in the development of cisplatin-induced nephrotoxicity. Currently, despite some deficiencies, hydration regimens remain the major protective measures against cisplatin-induced nephrotoxicity. Therefore, effective drugs must be explored and developed to prevent and treat cisplatin-induced kidney injury. In recent years, many natural compounds with high efficiency and low toxicity have been identified for the treatment of cisplatin-induced nephrotoxicity, including quercetin, saikosaponin D, berberine, resveratrol, and curcumin. These natural agents have multiple targets, multiple effects, and low drug resistance; therefore, they can be safely used as a supplementary regimen or combination therapy for cisplatin-induced nephrotoxicity. This review aimed to comprehensively describe the molecular mechanisms underlying cisplatin-induced nephrotoxicity and summarize natural kidney-protecting compounds to provide new ideas for the development of better therapeutic agents.

Keywords: Cisplatin; Mechanisms; Natural compounds; Nephrotoxicity; Renoprotective.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Apoptosis
  • Cisplatin / toxicity
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Kidney
  • Neoplasms* / metabolism
  • Oxidative Stress

Substances

  • Cisplatin
  • Antineoplastic Agents